Company Lexington Biosciences, Inc. Canadian Securities Exchange
Equities
LNB
CA5290204067
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +6.67% | +166.67% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 16/20/16 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21/16/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21/16/21 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 23,669,560 | 0 | 0 | 13.79 % |
Stock B | 1 | 3,786,840 | 3,785,340 ( 99.96 %) | 0 |
Company contact information
Lexington Biosciences, Inc.
1055 West Hastings Street Suite 1900
V6E 2E9, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-6.46% | 18TCr | |
+3.39% | 11TCr | |
-3.68% | 6.85TCr | |
+5.44% | 5.2TCr | |
+5.70% | 4.41TCr | |
+4.37% | 4.22TCr | |
+25.42% | 3.24TCr | |
+14.52% | 2.64TCr | |
-4.29% | 2.5TCr |
- Stock Market
- Equities
- LXGTF Stock
- LNB Stock
- Company Lexington Biosciences, Inc.